Somatostatin inhibits prolactin release from the lactotroph primed with oestrogen and cyproterone acetate in man
- 1 December 1984
- journal article
- research article
- Published by Bioscientifica in Journal of Endocrinology
- Vol. 103 (3), 333-335
- https://doi.org/10.1677/joe.0.1030333
Abstract
The present study investigated the effect of administration of somatostatin (SRIF) on the release of prolactin in men. No effect was observed when SRIF was administered to eugonadal men. Release of prolactin was inhibited, however, when SRIF was administered to oestrogen-treated agonadal subjects (male-to-female trans-sexuals) and to an even greater degree when subjects had been pretreated with a combination of oestrogen and cyproterone acetate. This is consistent with findings in the rat. Thus in man, as in the rat, SRIF can inhibit prolactin secretion, but only after treatment with oestrogen. J. Endocr. (1984) 103, 333–335This publication has 5 references indexed in Scilit:
- Somatostatin Inhibits prolactin secretion in the estradiol primed male ratCanadian Journal of Physiology and Pharmacology, 1981
- Hyperprolactinemia in monkeys: Induction by an estrogen-progesterone synergySteroids, 1981
- THE INFLUENCE OF AMINO ACIDS AND SOMATOSTATIN ON PROLACTIN AND GROWTH HORMONE RELEASE IN MANActa Endocrinologica, 1979
- Potent Antidopaminergic Activity of Estradiol at the Pituitary Level on Prolactin ReleaseScience, 1978
- Pituitary and Extrapituitary Effects of Somatostatin in Normal ManHormone and Metabolic Research, 1976